---
document_datetime: 2025-11-23 08:04:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/forcaltonin.html
document_name: forcaltonin.html
version: success
processing_time: 0.0798305
conversion_datetime: 2025-12-27 13:22:46.373508
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Forcaltonin

[RSS](/en/individual-human-medicine.xml/65460)

##### Withdrawn

This medicine's authorisation has been withdrawn

recombinant salmon calcitonin

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 October 2008, the marketing authorisation holder (MAH) responsible for Forcaltonin, Unigene UK Ltd, notified the European Commission of its decision to voluntarily withdraw the marketing authorisation for Forcaltonin for commercial reasons.

The MAH confirmed that this decision is not related to any safety concerns with Forcaltonin. Forcaltonin (recombinant salmon calcitonin) was indicated for the prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures, Paget's disease and hypercalcaemia of malignancy. Alternative treatments containing the same active substance as Forcaltonin (salmon calcitonin) are available throughout the European Union. On 29 October 2008, the European Commission issued a decision to withdraw the marketing authorisation for Forcaltonin.

Pursuant to this decision, the European public assessment report (EPAR) for Forcaltonin is updated to reflect that the marketing authorisation is no longer valid.

Forcaltonin : EPAR - Summary for the public

English (EN) (251.54 KB - PDF)

**First published:** 21/11/2008

**Last updated:** 21/11/2008

[View](/en/documents/overview/forcaltonin-epar-summary-public_en.pdf)

[Other languages (18)](#file-language-dropdown-647)

español (ES) (254.08 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/es/documents/overview/forcaltonin-epar-summary-public_es.pdf)

čeština (CS) (393.47 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/cs/documents/overview/forcaltonin-epar-summary-public_cs.pdf)

dansk (DA) (253.46 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/da/documents/overview/forcaltonin-epar-summary-public_da.pdf)

Deutsch (DE) (250.63 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/de/documents/overview/forcaltonin-epar-summary-public_de.pdf)

eesti keel (ET) (252.23 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/et/documents/overview/forcaltonin-epar-summary-public_et.pdf)

ελληνικά (EL) (436.18 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/el/documents/overview/forcaltonin-epar-summary-public_el.pdf)

français (FR) (254.94 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/fr/documents/overview/forcaltonin-epar-summary-public_fr.pdf)

italiano (IT) (253.54 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/it/documents/overview/forcaltonin-epar-summary-public_it.pdf)

latviešu valoda (LV) (399.28 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/lv/documents/overview/forcaltonin-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (369.98 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/lt/documents/overview/forcaltonin-epar-summary-public_lt.pdf)

magyar (HU) (385.67 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/hu/documents/overview/forcaltonin-epar-summary-public_hu.pdf)

Nederlands (NL) (254.06 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/nl/documents/overview/forcaltonin-epar-summary-public_nl.pdf)

polski (PL) (645.31 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/pl/documents/overview/forcaltonin-epar-summary-public_pl.pdf)

português (PT) (253.88 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/pt/documents/overview/forcaltonin-epar-summary-public_pt.pdf)

slovenčina (SK) (391.46 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/sk/documents/overview/forcaltonin-epar-summary-public_sk.pdf)

slovenščina (SL) (380.56 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/sl/documents/overview/forcaltonin-epar-summary-public_sl.pdf)

Suomi (FI) (252.88 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/fi/documents/overview/forcaltonin-epar-summary-public_fi.pdf)

svenska (SV) (253.6 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/sv/documents/overview/forcaltonin-epar-summary-public_sv.pdf)

## Product information

Forcaltonin : EPAR - Product Information

English (EN) (472.2 KB - PDF)

**First published:** 21/11/2008

**Last updated:** 21/11/2008

[View](/en/documents/product-information/forcaltonin-epar-product-information_en.pdf)

[Other languages (18)](#file-language-dropdown-710)

español (ES) (476.94 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/es/documents/product-information/forcaltonin-epar-product-information_es.pdf)

čeština (CS) (564.71 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/cs/documents/product-information/forcaltonin-epar-product-information_cs.pdf)

dansk (DA) (476.48 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/da/documents/product-information/forcaltonin-epar-product-information_da.pdf)

Deutsch (DE) (494.18 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/de/documents/product-information/forcaltonin-epar-product-information_de.pdf)

eesti keel (ET) (464.15 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/et/documents/product-information/forcaltonin-epar-product-information_et.pdf)

ελληνικά (EL) (680.46 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/el/documents/product-information/forcaltonin-epar-product-information_el.pdf)

français (FR) (482.69 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/fr/documents/product-information/forcaltonin-epar-product-information_fr.pdf)

italiano (IT) (474.51 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/it/documents/product-information/forcaltonin-epar-product-information_it.pdf)

latviešu valoda (LV) (582.26 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/lv/documents/product-information/forcaltonin-epar-product-information_lv.pdf)

lietuvių kalba (LT) (538.49 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/lt/documents/product-information/forcaltonin-epar-product-information_lt.pdf)

magyar (HU) (541.43 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/hu/documents/product-information/forcaltonin-epar-product-information_hu.pdf)

Nederlands (NL) (482.99 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/nl/documents/product-information/forcaltonin-epar-product-information_nl.pdf)

polski (PL) (585.1 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/pl/documents/product-information/forcaltonin-epar-product-information_pl.pdf)

português (PT) (479.26 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/pt/documents/product-information/forcaltonin-epar-product-information_pt.pdf)

slovenčina (SK) (537.95 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/sk/documents/product-information/forcaltonin-epar-product-information_sk.pdf)

slovenščina (SL) (528.25 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/sl/documents/product-information/forcaltonin-epar-product-information_sl.pdf)

Suomi (FI) (463.81 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/fi/documents/product-information/forcaltonin-epar-product-information_fi.pdf)

svenska (SV) (472.07 KB - PDF)

**First published:**

21/11/2008

**Last updated:**

21/11/2008

[View](/sv/documents/product-information/forcaltonin-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IA/0015 20/11/2008

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Forcaltonin : EPAR - All Authorised presentations

English (EN) (272.98 KB - PDF)

**First published:** 21/11/2008

**Last updated:** 21/11/2008

[View](/en/documents/all-authorised-presentations/forcaltonin-epar-all-authorised-presentations_en.pdf)

## Product details

Name of medicine Forcaltonin Active substance recombinant salmon calcitonin International non-proprietary name (INN) or common name recombinant salmon calcitonin Therapeutic area (MeSH)

- Hypercalcemia
- Osteitis Deformans
- Bone Resorption

Anatomical therapeutic chemical (ATC) code H05BA01

### Pharmacotherapeutic group

Calcium homeostasis

### Therapeutic indication

Calcitonin is indicated for:

- Prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures
- Paget's disease
- Hypercalcaemia of malignancy

## Authorisation details

EMA product number EMEA/H/C/000197 Marketing authorisation holder

Unigene UK Ltd.

191 Sparrows Herne Bushey Heath Hertfordshire WD23 1AJ United Kingdom

Marketing authorisation issued 11/01/1999 Withdrawal of marketing authorisation 29/10/2008

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Forcaltonin : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (245.4 KB - PDF)

**First published:** 21/11/2008

**Last updated:** 21/11/2008

[View](/en/documents/procedural-steps-after/forcaltonin-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Forcaltonin : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (490.47 KB - PDF)

**First published:** 21/11/2008

**Last updated:** 21/11/2008

[View](/en/documents/steps-after-cutoff/forcaltonin-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Forcaltonin : EPAR - Scientific Discussion

English (EN) (423.18 KB - PDF)

**First published:** 21/11/2008

**Last updated:** 21/11/2008

[View](/en/documents/scientific-discussion/forcaltonin-epar-scientific-discussion_en.pdf)

Forcaltonin : EPAR - Procedural steps taken before authorisation

English (EN) (308.04 KB - PDF)

**First published:** 21/11/2008

**Last updated:** 21/11/2008

[View](/en/documents/procedural-steps/forcaltonin-epar-procedural-steps-taken-authorisation_en.pdf)

**This page was last updated on** 20/11/2008

## Share this page

[Back to top](#main-content)